Increased BRD4-L and BRD4-S promotes chemotherapy resistance in ovarian carcinoma: Study
by Impact Journals LLCPatient-derived xenografts with high expression of BRD4-L and BRD4-S are resistant to cisplatin/paclitaxel chemotherapy. Credit:Genes & Cancer(2023). DOI: 10.1863
Updated on: January 17,2024
20
Increased BRD4-L and BRD4-S promotes chemotherapy resistance in ovarian carcinoma: Study
by Impact Journals LLCPatient-derived xenografts with high expression of BRD4-L and BRD4-S are resistant to cisplatin/paclitaxel chemotherapy. Credit:Genes & Cancer(2023). DOI: 10.1863
Updated on:January 17,2024
20